KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Free Cash Flow (2016 - 2025)

Opko Health (OPK) has disclosed Free Cash Flow for 16 consecutive years, with -$28.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow rose 42.62% year-over-year to -$28.6 million, compared with a TTM value of -$190.8 million through Dec 2025, up 8.48%, and an annual FY2025 reading of -$190.8 million, up 8.48% over the prior year.
  • Free Cash Flow was -$28.6 million for Q4 2025 at Opko Health, up from -$37.8 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $28.9 million in Q3 2023 and bottomed at -$86.7 million in Q2 2025.
  • Average Free Cash Flow over 5 years is -$27.9 million, with a median of -$31.1 million recorded in 2024.
  • The sharpest move saw Free Cash Flow soared 172.54% in 2023, then crashed 427.63% in 2024.
  • Year by year, Free Cash Flow stood at -$12.4 million in 2021, then tumbled by 206.76% to -$38.0 million in 2022, then dropped by 8.85% to -$41.3 million in 2023, then dropped by 20.59% to -$49.8 million in 2024, then soared by 42.62% to -$28.6 million in 2025.
  • Business Quant data shows Free Cash Flow for OPK at -$28.6 million in Q4 2025, -$37.8 million in Q3 2025, and -$86.7 million in Q2 2025.